arrow
J

Jean-Philippe Theurillat

Institute of Oncology Research
H指数:31
被引数:9,230

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting FOXA1 and FOXA2 disrupts the lineage-specific oncogenic output program in prostate cancer

靶向FOXA1和FOXA2破坏了前列腺癌中谱系特异性的致癌输出程序

2025-09-260
PREAI
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression

JUN介导衰老相关的分泌表型和免疫细胞募集以预防前列腺癌进展

2024-05-292
OAAI
Minor intron splicing is critical for survival of lethal prostate cancer

次要内含子剪接对于致死性前列腺癌的生存至关重要

2023-06-017
OA
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
2021-12-0243
OAAI
Patient-derived xenografts and organoids model therapy response in prostate cancer
2021-02-1899
OAAI
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer

SPOP和ERG的双重功能决定了前列腺癌的雄激素治疗反应

2021-02-0234
OAAI
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer
2021-01-2632
OAAI
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer
2020-04-230
OAAI
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo
2020-04-0630
OA
De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders
2020-03-0113
OAAI
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
2017-08-14150
OAAI